Biochemist Sharon Stack hopes to advance the field of ovarian cancer by exploring the tumor and host-related factors that influence its metastatic process.

or primary peritoneal cancers. In mouse models, they found, niraparib slowed down the progression of atherosclerosis and ...

This is the poem I wrote to help myself cope with my new diagnosis. It served as a reminder that I was resilient.

For many, the walk is a chance to bond with other survivors, but for others, the relay is a chance to celebrate the memory of ...

In the heart of every community lies the spirit of resilience and compassion, often embodied by individuals who dedicate their lives to serving others. Among these unsung heroes stands Karen, a ...

Apr. 29, 2024 — Researchers have developed a model of Kaposi sarcoma that could expedite the development of new drugs to treat the disease, which is the most common cancer in people living with ...

Adding olaparib to maintenance therapy with bevacizumab was associated with significantly longer survival for patients with ...

Shoot for the stars while the moon sails through your exploratory ninth house until late afternoon on Saturday. Pursue a novel experience that forces you to stretch, whether it’s showing up at a ...

In January, BioNTech and DualityBio received Fast Track designation for BNT325/DB-1305 from the U.S. FDA for the treatment of patients with platinum-resistant ovarian epithelial, fallopian tube, or ...

DelveInsight's Malignant Ascites Market Insights report includes a comprehensive understanding of current treatment practices ...